Evidence map›Paper›PMID 32850803›Full record

ArticleFrontiers in cell and developmental biology2020

Further Evidence That MicroRNAs Can Play a Role in Hemophilia A Disease Manifestation:

Katarzyna I Jankowska, Joseph McGill, Behnaz Pezeshkpoor, Johannes Oldenburg, Zuben E Sauna, Chintamani D Atreya

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. The Epigenetic Landscape of Hemophilia.Current molecular medicine · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Experimental validation of a predicted microRNA within humanMolecular biology research communications · 2021
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Katarzyna I JankowskaOBRR/DBCD/LCH in the Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Joseph McGillOTAT/DPPT/HB in the Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Behnaz PezeshkpoorInstitute of Experimental Hematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Johannes OldenburgInstitute of Experimental Hematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Zuben E SaunaOTAT/DPPT/HB in the Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Chintamani D AtreyaOBRR/DBCD/LCH in the Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Center for Biologics Evaluation and Research · USUnited States Food and Drug Administration · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemophilia A (HA) is a

Indexed as

coagulation factor VIIIFVIII deficiencyhemophilia AmicroRNARNA affinity purificationthrombosis

Identifiers

PMID32850803
PMCPMC7406646
OpenAlexW3045973725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.